Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis
DermatologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
- Publicado em
- 20 abr 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis
N N Alrabadi, H M Abushukair, O E Ababneh, S S Syaj, S S Al-Horani, A A Qarqash, O A Darabseh, M M Al-Sous, S R Al-Aomar, Y B Ahmed et al.
Descritores MeSH
- Ipilimumab
- Skin Neoplasms
- Nivolumab
- Melanoma
- Immune Checkpoint Inhibitors
- Antineoplastic Agents, Immunological
- Middle Aged
- Retrospective Studies
- Randomized Controlled Trials as Topic
- Disease Progression